0.9729
price down icon2.71%   -0.0271
pre-market  시장 영업 전:  1.00   0.0271   +2.79%
loading
전일 마감가:
$1.00
열려 있는:
$1.01
하루 거래량:
1.75M
Relative Volume:
1.07
시가총액:
$112.20M
수익:
$13.45M
순이익/손실:
$-178.23M
주가수익비율:
-0.5896
EPS:
-1.65
순현금흐름:
$-132.53M
1주 성능:
-9.92%
1개월 성능:
-8.22%
6개월 성능:
+2.41%
1년 성능:
-72.36%
1일 변동 폭
Value
$0.95
$1.015
1주일 범위
Value
$0.95
$1.10
52주 변동 폭
Value
$0.6611
$4.20

Fate Therapeutics Inc Stock (FATE) Company Profile

Name
명칭
Fate Therapeutics Inc
Name
전화
858.875.1803
Name
주소
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA
Name
직원
181
Name
트위터
@fatethx
Name
다음 수익 날짜
2025-08-08
Name
최신 SEC 제출 서류
Name
FATE's Discussions on Twitter

FATE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
FATE
Fate Therapeutics Inc
0.9729 118.79M 13.45M -178.23M -132.53M -1.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Fate Therapeutics Inc Stock (FATE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-11-18 업그레이드 BofA Securities Underperform → Neutral
2024-06-17 업그레이드 Piper Sandler Neutral → Overweight
2023-03-27 재개 Wells Fargo Equal Weight
2023-01-24 다운그레이드 H.C. Wainwright Buy → Neutral
2023-01-06 다운그레이드 BMO Capital Markets Outperform → Market Perform
2023-01-06 다운그레이드 BofA Securities Buy → Underperform
2023-01-06 다운그레이드 Cowen Outperform → Market Perform
2023-01-06 다운그레이드 Piper Sandler Overweight → Neutral
2023-01-06 다운그레이드 Stifel Buy → Hold
2023-01-06 다운그레이드 Truist Buy → Hold
2023-01-06 다운그레이드 Wedbush Outperform → Neutral
2023-01-03 다운그레이드 Guggenheim Buy → Neutral
2022-12-22 다운그레이드 Oppenheimer Outperform → Perform
2022-12-15 개시 Goldman Sell
2022-11-04 재개 Cantor Fitzgerald Overweight
2022-10-10 개시 Canaccord Genuity Buy
2022-08-18 재개 Wells Fargo Overweight
2022-07-28 개시 Needham Hold
2022-07-11 업그레이드 BMO Capital Markets Market Perform → Outperform
2022-06-03 개시 Robert W. Baird Neutral
2022-02-11 재개 BMO Capital Markets Market Perform
2021-12-15 업그레이드 Wedbush Neutral → Outperform
2021-12-07 개시 Cowen Outperform
2021-11-09 업그레이드 Citigroup Neutral → Buy
2021-08-26 개시 Morgan Stanley Equal-Weight
2021-06-07 업그레이드 H.C. Wainwright Neutral → Buy
2021-05-07 업그레이드 Wedbush Neutral → Outperform
2021-04-26 재개 Jefferies Buy
2021-02-26 개시 BofA Securities Buy
2021-02-26 다운그레이드 Wedbush Outperform → Neutral
2021-02-11 다운그레이드 Citigroup Buy → Neutral
2021-01-27 재개 H.C. Wainwright Neutral
2020-05-13 개시 H.C. Wainwright Buy
2020-03-04 개시 Barclays Overweight
2020-01-09 다운그레이드 BMO Capital Markets Outperform → Market Perform
2019-12-30 재확인 Mizuho Buy
2019-12-09 업그레이드 Wells Fargo Market Perform → Outperform
2019-11-12 개시 SunTrust Buy
2019-11-06 다운그레이드 Wells Fargo Outperform → Market Perform
2019-10-01 개시 Stifel Buy
2019-08-09 개시 BTIG Research Buy
2019-07-22 개시 Cantor Fitzgerald Overweight
2019-07-12 개시 Oppenheimer Outperform
2019-06-13 개시 Mizuho Buy
2019-06-07 개시 ROTH Capital Neutral
2019-05-31 개시 Guggenheim Buy
2019-05-24 재개 Citigroup Buy
2019-03-28 개시 SVB Leerink Outperform
2019-01-03 다운그레이드 Stephens Overweight → Equal-Weight
2018-11-05 개시 Jefferies Buy
2018-08-01 개시 Citigroup Buy
2018-03-06 다운그레이드 H.C. Wainwright Buy → Neutral
모두보기

Fate Therapeutics Inc 주식(FATE)의 최신 뉴스

pulisher
12:50 PM

What are analysts’ price targets for Fate Therapeutics Inc.2025 Market Overview & Smart Swing Trading Alerts - khodrobank.com

12:50 PM
pulisher
Sep 04, 2025

Volume spikes in Fate Therapeutics Inc. stock – what they meanMarket Sentiment Summary & High Conviction Buy Zone Picks - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Does Fate Therapeutics Inc. show high probability of rebound2025 Geopolitical Influence & High Accuracy Investment Signals - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Visual trend scoring systems applied to Fate Therapeutics Inc.Market Activity Recap & Risk Controlled Stock Pick Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Detecting support and resistance levels for Fate Therapeutics Inc.Weekly Stock Recap & Target Return Focused Picks - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Can volume confirm reversal in Fate Therapeutics Inc.2025 Fundamental Recap & Technical Buy Zone Confirmation - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Institutional scanner results for Fate Therapeutics Inc.Trade Volume Summary & Growth Focused Entry Point Reports - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Will Fate Therapeutics Inc. bounce back from current supportPortfolio Risk Report & Weekly High Conviction Trade Ideas - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Is Fate Therapeutics Inc. trending in predictive chart modelsWeekly Trade Recap & Real-Time Stock Movement Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can machine learning forecast Fate Therapeutics Inc. recoveryPrice Action & Stock Market Timing Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Fate Therapeutics' Equity Incentive Strategy and Its Implications for Talent Retention and Long-Term Value Creation - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 03, 2025
pulisher
Sep 03, 2025

Fate Therapeutics shares rise 3% after-hours following new employee inducement grants. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Is Fate Therapeutics Inc. stock entering bullish territoryTrade Exit Summary & Weekly High Potential Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Leerink Partners lowers Fate Therapeutics stock price target to $7 on iPSC CAR’iT pivot - Investing.com Canada

Sep 03, 2025
pulisher
Sep 03, 2025

Does Fate Therapeutics Inc. align with a passive investing strategyInflation Watch & Consistent Income Trade Recommendations - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Heatmap analysis for Fate Therapeutics Inc. and competitorsJuly 2025 WrapUp & Fast Gain Stock Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What are Fate Therapeutics Inc.’s recent SEC filings showingQuarterly Profit Review & Breakout Confirmation Trade Signals - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Using data models to predict Fate Therapeutics Inc. stock movementJuly 2025 Macro Moves & Weekly High Return Stock Forecasts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What MACD and RSI say about Fate Therapeutics Inc.Quarterly Profit Report & AI Powered Market Trend Analysis - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Why Fate Therapeutics Inc. stock attracts strong analyst attentionTrade Analysis Summary & Short-Term Trading Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Layoff Tracker: Novartis Continues Cutting Spree With 58 Sacked in New Jersey - BioSpace

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 09:36:15 - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Has Fate Therapeutics Inc. found a price floorWall Street Watch & Risk Managed Trade Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will Fate Therapeutics Inc. stock hit new highs in YEARJuly 2025 PostEarnings & Real-Time Chart Pattern Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Chart overlay techniques for tracking Fate Therapeutics Inc.2025 Technical Patterns & Entry and Exit Point Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Building trade automation scripts for Fate Therapeutics Inc.M&A Rumor & Low Risk Entry Point Tips - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Backtesting results for Fate Therapeutics Inc. trading strategiesMarket Trend Review & Smart Allocation Stock Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Market reaction to Fate Therapeutics Inc.’s recent newsJuly 2025 Recap & High Accuracy Investment Entry Signals - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Is Abeona Therapeutics Inc. attractive at current valuation2025 Macro Impact & Consistent Return Investment Signals - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

What is Fate Therapeutics Inc. s 5 year growth outlookTrade Volume Report & Weekly Breakout Stock Alerts - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Is Fate Therapeutics Inc. forming a bottoming baseJuly 2025 Sector Moves & Stock Portfolio Risk Management - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Fate Therapeutics Inc. Crosses 200 Day MA — Signal or Noise getLinesFromResByArray error: size == 0 - 강소기업뉴스

Sep 01, 2025
pulisher
Sep 01, 2025

Will Fate Therapeutics Inc. stock go up soon2025 Volume Leaders & Technical Analysis for Trade Confirmation - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Comparing Fate Therapeutics Inc. in custom built stock radarsRisk Management & Weekly Top Performers Watchlists - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

What is Fate Therapeutics Inc.’s valuation compared to sectorMarket Activity Report & Fast Entry Momentum Alerts - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Published on: 2025-09-01 01:36:52 - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Fate Therapeutics Inc. stock trend forecastEarnings Summary Report & Community Driven Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Understanding Fate Therapeutics Inc.’s price movementMarket Movement Recap & Real-Time Buy Zone Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How to interpret RSI for Fate Therapeutics Inc. stockLong Setup & Advanced Technical Analysis Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Tick level data insight on Fate Therapeutics Inc. volatilityWeekly Trade Report & Low Risk Investment Opportunities - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Fate Therapeutics Inc. stock momentum explainedPortfolio Gains Report & Consistent Income Trade Ideas - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

RSI Crosses Above 30 for Fate Therapeutics Inc. — Reversal in Sight2025 Key Lessons & Fast Gain Swing Alerts - beatles.ru

Aug 31, 2025
pulisher
Aug 31, 2025

Can technical indicators confirm Fate Therapeutics Inc.’s reversalJuly 2025 PostEarnings & Daily Price Action Insights - Newser

Aug 31, 2025

Fate Therapeutics Inc (FATE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Fate Therapeutics Inc 주식 (FATE) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Valamehr Bahram
President and CEO
Aug 04 '25
Sale
1.06
14,466
15,396
334,898
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
자본화:     |  볼륨(24시간):